{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:31:39Z","timestamp":1768710699978,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"sceptre cg seed grant","award":["NMRC\/CG\/M008\/2017"],"award-info":[{"award-number":["NMRC\/CG\/M008\/2017"]}]},{"name":"national university heart centre singapore (nuhcs) cardiovascular research institute (cvri) - core fund","award":["NUHSRO\/2019\/082\/Core"],"award-info":[{"award-number":["NUHSRO\/2019\/082\/Core"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10557-021-07266-z","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T04:03:02Z","timestamp":1635307382000},"page":"605-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Model-Based Risk Prediction of Rivaroxaban with Amiodarone for Moderate Renal Impaired Elderly Population"],"prefix":"10.1007","volume":"37","author":[{"given":"Ziteng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor Jing Yi","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pipin","family":"Kojodjojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6107-9072","authenticated-orcid":false,"given":"Eric Chun Yong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"7266_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","volume":"53","author":"W Mueck","year":"2014","unstructured":"Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet. 2014;53:1\u201316.","journal-title":"Clin Pharmacokinet"},{"key":"7266_CR2","doi-asserted-by":"publisher","unstructured":"Gronich N, Stein N, Muszkat M. Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study. Clin Pharmacol Ther. 2021;cpt.2369.\u00a0https:\/\/doi.org\/10.1002\/cpt.2369","DOI":"10.1002\/cpt.2369"},{"key":"7266_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1753944716663156","volume":"11","author":"R Shah","year":"2017","unstructured":"Shah R, Patel MR. Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practice. Ther Adv Cardiovasc Dis. 2017;11:105\u201320.","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"7266_CR4","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.jacc.2018.01.044","volume":"71","author":"EJY Cheong","year":"2018","unstructured":"Cheong EJY, Goh JJN, Hong Y, Kojodjojo P, Chan ECY. Rivaroxaban with and without amiodarone in renal impairment. J Am Coll Cardiol. 2018;71:1395\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"7266_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1124\/dmd.119.086918","volume":"47","author":"EJY Cheong","year":"2019","unstructured":"Cheong EJY, Teo DWX, Chua DXY, Chan ECY. Systematic development and verification of a physiologically based pharmacokinetic model of rivaroxaban. Drug Metab Dispos. 2019;47:1291\u2013306.","journal-title":"Drug Metab Dispos"},{"key":"7266_CR6","doi-asserted-by":"publisher","first-page":"100390","DOI":"10.1016\/j.dmpk.2021.100390","volume":"38","author":"HL Tan","year":"2021","unstructured":"Tan HL, Tang LWT, Chin SY, Chan ECY. Investigation of the arcane inhibition of human organic anion transporter 3 by benzofuran antiarrhythmic agents. Drug Metab Pharmacokinet. 2021;38:100390.","journal-title":"Drug Metab Pharmacokinet"},{"key":"7266_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1124\/dmd.116.073890","volume":"45","author":"EJY Cheong","year":"2017","unstructured":"Cheong EJY, Goh JJN, Hong Y, Venkatesan G, Liu Y, Chiu GNC, et al. Application of static modeling \u00ad\u00adin the prediction of in vivo drug\u2013drug interactions between rivaroxaban and antiarrhythmic agents based on in vitro inhibition studies. Drug Metab Dispos. 2017;45:260\u20138.","journal-title":"Drug Metab Dispos"},{"key":"7266_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/cpt.750","volume":"103","author":"C-H Hsueh","year":"2018","unstructured":"Hsueh C-H, Hsu V, Zhao P, Zhang L, Giacomini KM, Huang S-M. PBPK modeling of the effect of reduced kidney function on the pharmacokinetics of drugs excreted renally by organic anion transporters. Clin Pharmacol Ther. 2018;103:485\u201392.","journal-title":"Clin Pharmacol Ther"},{"key":"7266_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41:67\u201376.","journal-title":"Drug Metab Rev"},{"key":"7266_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2215\/CJN.02170218","volume":"14","author":"N Jain","year":"2019","unstructured":"Jain N, Reilly RF. Clinical Pharmacology of oral anticoagulants in patients with kidney disease. CJASN. 2019;14:278\u201387.","journal-title":"CJASN"},{"key":"7266_CR11","unstructured":"European Medicines Agency. Xarelto (rivaroxaban). Summary of product characteristics [Internet]. 2009. Available from:\u00a0https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/xarelto-epar-product-information_en.pdf. Accessed 9 Sep 2021."},{"key":"7266_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijcard.2015.06.081","volume":"201","author":"C St\u00f6llberger","year":"2015","unstructured":"St\u00f6llberger C, Bastovansky A, Finsterer J. Fatal intracerebral bleeding under rivaroxaban. Int J Cardiol. 2015;201:110\u20132.","journal-title":"Int J Cardiol"},{"key":"7266_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/bcpt.13419","volume":"127","author":"K Skov","year":"2020","unstructured":"Skov K, Falskov B, Jensen EA, Dorff MH. Supratheraputic rivaroxaban levels: a persistent drug-drug interaction after discontinuation of amiodarone. Basic Clin Pharmacol Toxicol. 2020;127:351\u20133.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"7266_CR14","first-page":"1","volume":"2018","author":"O Oladiran","year":"2018","unstructured":"Oladiran O, Segal J, Nwosu I, Nazir S. A rare case of spontaneous cardiac tamponade induced by concomitant use of rivaroxaban and amiodarone. Case Rep Cardiol. 2018;2018:1\u20134.","journal-title":"Case Rep Cardiol"},{"key":"7266_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cpt.2125","volume":"110","author":"T Heimbach","year":"2020","unstructured":"Heimbach T, Chen Y, Chen J, Dixit V, Parrott N, Peters SA, et al. Physiologically-based pharmacokinetic modeling in renal and hepatic impairment populations: a pharmaceutical industry perspective. Clin Pharmacol Ther. 2020;110:297\u2013310.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-021-07266-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T07:06:23Z","timestamp":1683356783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-021-07266-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7266"],"URL":"https:\/\/doi.org\/10.1007\/s10557-021-07266-z","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"13 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication\/Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}